Page 25 - Ram Prasad Sahu

IPCA Labs stock hits valuation hurdle on Unichem stake acquisition

Improving growth and expanding margins in competitive US market will be key challenges

Energy business powers RIL: Q4 beats Street, outlook positive for stock

Improved performance in consumer biz, its proposed listing remain key triggers

Export, demand slowdown may hurt Schaeffler India's near-term prospects

March quarter earnings were below estimates due to weak show of industrial segment

Tyre stocks may rerate on sustained demand momentum, margin gains

Recovery in the replacement segment and sales to auto makers to drive volumes

Two-wheel rides saddle up: Growth recovery, valuations to kick-start gains

Eicher hot on the trail of TVS, which is a top pick of most brokerages

Sequential gains in Q4, improving earnings trajectory for Divi's Labs

Brokerages expect a sequential improvement in margins

Weak sales growth weighs on Avenue Supermarts, operational parameters weak

Stock correction was also on account of margin concerns

Weak demand, excess supply get tile makers walking on eggshells

Although lower gas prices could offer some relief on margins

Oberoi Realty to build on new project launches, rental portfolio

Street will track pace of bookings, project execution, and acquisition of new land

From Bandhan Bank to Ashok Leyland, stocks ripe for cherry-picking

With indices getting back on their feet, can stocks be far behind? Here is the list of 10 such stocks from BSE 100 with huge upside promise for investors willing to ride out any potential volatility

Growth, margins play whack-a-mole with consumer discretionary space

Some brokerages bet on consumer staples, preferring this more defensive space

New guidelines, higher M&HCV demand to drive gains for Bosch stock

Strong volume growth in its core segments of M&HCV/tractors should help keep the sales trajectory elevated

Future bets: LIC to Axis Bank, here're 10 bright spots to keep an eye on

The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks

No rerating yet for diagnostic players despite price hikes as margins fall

While discounts have come down, pricing gap still large between incumbents and new players

Specialty scale-up, product mix: Sun's medicine cabinet piques brokerages

In the near term, higher R&D costs and a recent acquisition to weigh on earnings growth

Multiple triggers likely to help Zydus to continue with its outperformance

New launches in the US, market share gains and steady domestic growth are positives

Near-term demand worries likely to weigh on Page Industries stock

Brokerages have mixed view after correction in stock price

No rerating yet for diagnostic players despite price hikes as margins fall

While discounts have come down, pricing gap still large between incumbents and new players

Rural recovery, price cuts to drive volume gains for consumer companies

It's 'rule Britannia' for brokerages; analysts divided on extent of margin gains

Further paring of stake will remain an overhang for Samvardhana Motherson

Given the Japanese company's remaining stake in SAMIL and 25.34 per cent stake in Motherson Sumi Wiring India, investors will keep an eye on the continued participation of the joint venture partner